Articles about CAR T immunotherapy

Sonoma Biotherapeutics raises $265M to advance therapies for autoimmune, inflammatory diseases

Seattle and South San-Francisco based preclinical biotech company Sonoma Biotherapeutics has raised $265 million in new funding, the company announced… Read More

Researchers create synthetic proteins that use logic to choose which cells to kill

The age of molecular-scale computing is entering a new era, thanks to the development of a system that uses synthetic… Read More

Thin metal films loaded with immune cells show promise as cancer therapy

Researchers at Seattle’s Fred Hutchinson Cancer Research Center have demonstrated the effectiveness of a new method for getting immune cells… Read More

Seattle Children’s opens a ‘cure factory’ to explore treatments for childhood cancer and other diseases

Maryn Sage remembers the words she heard on the day she learned that her 16-year-old son, Jedd Feliciano, was cancer-free.… Read More

Merck research chief Roger Perlmutter touts Seattle biotech strength after $300M Immune Design deal

Two months after Merck acquired Seattle-based biotech Immune Design for $300 million, the president of Merck Research Laboratories, Roger Perlmutter,… Read More

Celgene CEO: Treating cancer is becoming ‘ironically easy’ — now the problem is affordability

BELLEVUE, Wash. — Cancer treatments have improved astronomically in the past few decades. But as more patients overcome the disease,… Read More

Groundbreaking study of cancer-killing immunotherapy could reduce side effects and improve performance

The emerging form of cancer treatment called CAR T immunotherapy is wiping out the disease in some terminal patients — but… Read More

Podcast

How this cancer therapy went from scientific underdog to potential cure

Nearly 40 years ago, scientists had what seemed like a crazy idea: What if we could reprogram cancer patients’ immune… Read More

Seattle Children’s launches into solid tumor treatments with new CAR T immunotherapy trial

Seattle Children’s Research Institute is launching a clinical trial that will examine a new kind of cancer-fighting treatment. The treatment… Read More

Fred Hutch study: Nanoparticles could help cutting-edge therapies get inside solid tumors

CAR T immunotherapies are one of the hottest topics of research — and investment — in the world of medicine today. The emerging… Read More

Seattle Children’s aims to cure terminal brain cancer using immunotherapy with new BrainChild initiative

When Avery Berg was diagnosed with aggressive, late-stage brain cancer at just 10 years old, she fought hard to stay… Read More

Seattle Children’s launches CureWorks, a project aimed at revolutionizing cancer treatment for kids

New cancer immunotherapies could revolutionize how we treat the disease, but for many children, those treatments are far out of… Read More

New immunotherapy study aims to prevent children with leukemia from relapsing

When scientists at Seattle Children’s Research Institute began studying a new immunotherapy cancer treatment a few years ago, they found… Read More

Juno finds clinical success with cancer drug, beats analyst expectations with $44M in revenue

Juno Therapeutics, the Seattle-based biotech company developing immunotherapy cancer treatments, unveiled promising new data from a study on its flagship… Read More

New study could point to solution for deadly immunotherapy side effects

CAR T immunotherapies — which genetically program immune cells to fight cancer — hold incredible promise for cancer patients who… Read More

Juno Therapeutics’ giant new Seattle HQ is designed to destroy cancer

When you walk into Juno Therapeutics‘ new headquarters in Seattle, your eyes are immediately drawn to the view. The office’s… Read More

Fred Hutch licenses new immunotherapy treatment to Mustang Bio, preps clinical trials in Seattle

A new immunotherapy technology developed at Seattle’s Fred Hutchinson Cancer Research Center has been licensed to New York-based Mustang Bio,… Read More

Landmark FDA approval clears the way for gene therapy treatments that fight cancer

The Food and Drug Administration announced Wednesday that it has approved the first CAR T immunotherapy in the United States,… Read More

Juno Therapeutics posts mixed results, remains optimistic about treatment pipeline

Seattle-based biotech company Juno Therapeutics beat analyst expectations in its second quarter revenue Thursday, reporting $21.3 million in revenue for… Read More